SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008860
Filing Date
2022-05-16
Accepted
2022-05-16 07:31:32
Documents
95
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20220331x10q.htm   iXBRL 10-Q 1775786
2 EX-31.1 ipsc-20220331xex31d1.htm EX-31.1 11875
3 EX-31.2 ipsc-20220331xex31d2.htm EX-31.2 11717
4 EX-32.1 ipsc-20220331xex32d1.htm EX-32.1 6202
5 EX-32.2 ipsc-20220331xex32d2.htm EX-32.2 6196
  Complete submission text file 0001558370-22-008860.txt   8463113

Data Files

Seq Description Document Type Size
6 EX-101.SCH ipsc-20220331.xsd EX-101.SCH 67743
7 EX-101.CAL ipsc-20220331_cal.xml EX-101.CAL 75424
8 EX-101.DEF ipsc-20220331_def.xml EX-101.DEF 266374
9 EX-101.LAB ipsc-20220331_lab.xml EX-101.LAB 580293
10 EX-101.PRE ipsc-20220331_pre.xml EX-101.PRE 457407
89 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20220331x10q_htm.xml XML 1417575
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 22925485
SIC: 2836 Biological Products, (No Diagnostic Substances)